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Abstract: The acute effect of crude extract, n-butanol and aqueous residual fractions 
of Musa x paradisiaca L., Musaceae, leaves on glycemia, serum insulin secretion and 
glycogen content in an in vivo approach was evaluated. In addition, the in vitro effect 
on disaccharidases activity and albumin glycation was studied. The crude extract and 
fractions, n-butanol and aqueous residual, reduced glycemia and increased liver glycogen 
content in hyperglycemic rats, inhibited maltase activity and the formation of advanced 
glycation end-products in vitro. Also, a signifi cant increase in insulin secretion and 
muscle glycogen content in hyperglycemic rats was observed with oral administration 
of the n-butanol fraction. Phytochemical analysis demonstrated the presence of rutin in 
crude extract and fractions of M. x paradisiaca leaves as the major compound. These 
benefi cial effects on the regulation of glucose homeostasis observed for M. x paradisiaca 
leaves and the presence of rutin as the major compound indicate potential anti-diabetic 
properties, since previous studies have been reported that rutin can modulate glucose 
homeostasis.
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Introduction
 Diabetes mellitus is the most common metabolic 
disorder and is a major cause of ill health all over the world. 
It is caused by defects in insulin secretion or action and, 
consequently, is characterized by hyperglycemia. Several 
pathogenic processes are involved in the development of 
diabetes and the chronic hyperglycemia is associated with 
long-term damage, dysfunction and failure of different 
organs, especially the eyes, kidneys, nerves, heart, and 
blood vessels. Treatment of hyperglycemia in diabetes 
involves diet control, exercise and the use of oral anti-
diabetic drugs, insulin therapy or combination of both 
(American Diabetes Association, 2011). Nonetheless, they 
fail to alter the course of complications and tend to result 
in undesirable side effects.
 Plants continue to be an important source of 
bioactive compounds and involve a multidisciplinary 
approach combining ethnobotanical, phytochemical and 
biological techniques to provide new chemical compounds. 
For many years people have used plants to treat diabetes. 
In this context, the hypoglycemic effect of several plants 
used as antidiabetic remedies has been confi rmed, and the 
mechanisms of hypoglycemic activity of these plants and 
their major compounds are being investigated (Jung et al., 
2006).
 Musa x paradisiaca L., Musaceae, popularly 
known as ‘banana’, is a perennial tree-like herb cultivated 
in many tropical and subtropical regions around the 
world. Banana, eaten as a fruit or a vegetable, is one of 
the most important crops in several countries due to its 
enriched food and versatile medicinal value. Various parts 
of the Musa plants have been used orally or topically 
as remedies in folk medicine and some studies have 
demonstrated this medicinal potential. The fruits, peel, 
leaves, roots and pseudostem of Musa plants have shown 
antiulcerogenic, antioxidant and antimicrobial activity, 
among others activities (Pannangpetch et al., 2001; Eleazu 
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et al., 2010; Karadi et al., 2011). In addition, studies have 
shown that some species of Musa possess antidiabetic, 
antihyperglycemic and hypoglycemic activity (Ojewole 
& Adewunmi, 2003; Mallick et al., 2006; Adewoye et al., 
2009).
 The presence of bioactive compounds like 
apigenin glycosides, myricetin glycoside, myricetin-3-
O-rutinoside, naringenin glycosides, kaempferol-3-O-
rutinoside, dopamine, N-acetyl serotonin, and rutin, has 
been reported in different species of Musa (Pothavorn et 
al., 2010). However, as far as we aware, there is no reports 
concerning chemical characterization and pharmacological 
properties of their leaves. Thus, the aim of the present 
study was to investigate the in vivo and in vitro effect of 
crude extract, n-butanol and aqueous residual fractions of 
leaves of Musa x paradisiaca on serum glucose levels, 
insulin secretion, liver and muscle glycogen content, 
serum albumin glycation and intestinal disaccharidase 
activity. Also, a phytochemical characterization of crude 
extract and fractions was carried out.
Material and Methods
Chemicals
 Rutin (≥98%), glycogen, bovine serum albumin 
(BSA), tolbutamide were purchased from Sigma Chemical 
Company® (St. Louis, MO, USA). Glucose, fructose, 
maltose, sucrose and all other solvents were purchased 
from Vetec® AG (Rio de Janeiro, Brazil). All reagents were 
of analytical grade. The solvents used for HPLC analysis 
were purchased from Tedia® (HPLC grade; Fairfield, OH, 
USA). Enzyme-linked immunosorbent assay (ELISA) for 
the quantitative determination of rat insulin (catalogue no. 
EZRMI-13K) was purchased from Millipore (St Charles, 
MO, USA). 
Plant material
 Leaves of Musa x paradisiaca L., Musaceae, 
were collected in Florianópolis, State of Santa Catarina, 
Brazil, Fazenda Experimental da Ressacada (27º 41’ 
06.28” S; 48º32’ 38.81” O) in April 2008. The voucher 
specimen was identified by Dr. Geraldo Ceni Coelho and 
is deposited in the herbarium at Universidade Federal de 
Santa Catarina (FLOR 3832).
Preparation of the extracts and fractions of Musa x 
paradisiaca
 The crude extract (CE) and fractions were 
prepared according to Costa et al. (2011) with minor 
modifications. Briefly, dried leaves (50 g) of M. x 
paradisiaca were crushed and extracted under reflux 
(90 ºC) with 500 mL of ethanol 40% (v/v) for 30 min. 
After cooling, the extract was filtered, the volume was 
adjusted to 500 mL with water, and the extract was 
separated into two fractions of 250 mL. One fraction 
was evaporated under reduced pressure to dryness to 
obtain CE. The ethanol content of the second fraction 
was removed under reduced pressure, its volume 
was adjusted to 250 mL with water, and this aqueous 
suspension was partitioned (3 x 100 mL) with n-BuOH, 
yielding the n-BuOH (BF) and aqueous residual 
fractions (ARF).
Chemical characterization of crude extract and fractions
 The presence of different constituents in 
crude extract and fractions from M. x paradisiaca was 
established by thin-layer chromatography (TLC) on 
silica gel plates (Merck 60 F254 20x20 cm) using several 
mobile phases. Detection was performed, respectively, 
with chlorosulfonic acid-glacial acetic acid reagent 
spraying and heating for terpenoids, and for phenolic 
compounds, fluorescence at 365 nm after spraying with 
1% diphenylboryloxyethylamine in MeOH. The high 
performance liquid chromatography (HPLC) analyses 
were performed in a PerkinElmer Series 200 HPLC, 
composed of a Photo Diode Array Detector (PDA), 
quaternary pump and autosampler. The data acquisition 
system was TotalChrom Workstation software. All 
samples were dissolved in MeOH:H2O (1:1 v/v), filtered 
using a 0.45 μm syringe filter (PVDF, Millipore®) and 
10 μL aliquots were injected for HPLC analysis. The 
extracts and fractions were analyzed at 1,000 mg/mL 
while the rutin standard solution was analyzed at 100 
μg/mL. The separation was performed on a Perkin 
Elmer Brownlee Choice C18 column (250 x 4.6 mm 
i.d.; 5μm) and the mobile phase used was a gradient of 
solvent A (acetonitrile) and solvent B (acetic acid 1%, 
adjusted to pH 3.0) as follow: 10-20% A (0-40 min) 
and isocratic 20% A (40-45 min). The flow rate was 
kept at 1.0 mL/min. The chromatograms were recorded 
at 340 nm while the UV spectra were monitored over 
the range of 200-450 nm. The flavonoids in the CE, 
BF and ARF of M. x paradisiaca were characterized 
by comparing the retention time and UV spectra with 
the reference standards, and by the co-injection of the 
sample and authentic samples (Costa et al., 2011).
In vivo assays
Animals
 The male Wistar rats (190-220 g) used in this 
study were bred in animal facility and housed in an air-
conditioned room (approximately 22 ºC) with controlled 
lighting on a 12:12 h light/dark cycle (lights on from 6 
to 18 h). The animals were maintained with pelleted food 
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(Nuvital, Nuvilab CR1, Curitiba, PR, Brazil), while tap 
water was available ad libitum. Fasted rats were deprived 
of food for at least 16 h but allowed free access to water. All 
the animals were monitored and maintained in accordance 
with the ethical recommendations of the Brazilian 
Veterinary Medicine Council and the Brazilian College 
of Animal Experimentation. This study was approved by 
the Committee for Ethics in Animal Research of UFSC 
(Protocol CEUA PP00398).
Oral glucose tolerance curve (OGTC)
 Fasted rats were divided into different groups of 
six animals for each treatment. Group I, hyperglycemic 
rats that received glucose (4 g/kg, 8.9 M); Group II, rats 
that received tolbutamide at a dose of 100 mg/kg; Group 
III, rats that received the CE at doses of 50, 100 and 200 
mg/kg; Group IV, rats that received BF at doses of 50 and 
100 mg/kg; Group V, rats that received ARF at doses of 
50 and 100 mg/kg. The glycemia was measured before the 
rats received the treatment (zero time). The rats were fed 
with extract and fractions (dissolved in water) and after 30 
min they were administered with glucose (4g/kg, 8.9 M) 
orally. The glycemia was measured at 15, 30, 60 and 180 
min after administration of glucose. All treatments were 
administrated by oral gavage.
Determination of the serum glucose concentration
 Blood samples were collected from the tail 
vein, centrifuged and the serum was used to determine 
the glycemia by glucose-oxidase colorimetric enzyme 
method according to the manufacturer’s instructions (Gold 
Analisa® commercial kit).
Glycogen content measurements
 The soleus muscle and liver were harvested 
from untreated hyperglycemic rats, treated with CE (200 
mg/kg), BF (50 mg/kg) and ARF (100 mg/kg) and used 
for the assay of glycogen content immediately after 3 
h of treatment. Glycogen was isolated from tissues as 
described by Krisman (1962). The tissues were weighed, 
homogenized in 33% KOH and boiled at 100 °C for 20 
min, with occasional stirring. After cooling, 96% ethanol 
was added to the samples which were then heated to boiling 
followed by cooling in an ice bath to aid the precipitation 
of glycogen. The homogenates were centrifuged at 1300 x 
g for 15 min, the supernatant was discarded and the pellets 
were neutralized with saturated NH4Cl before being 
maintained at 100 °C for 5 min, washed and resolubilized 
in water. Glycogen content was determined by treatment 
with iodine reagent and the absorbance was measured at 
460 nm. The results are expressed as mg of glycogen/g of 
tissue.
Insulin serum measurements
 The insulin levels were measured by enzyme-
linked immunosorbent assay (ELISA) according to the 
manufacturer’s instructions. The range of values detected 
by this assay was 0.2 ng/mL to 10 ng/mL. The intra- and 
inter-assay coefficients of variation (CV) for insulin were 
3.22 and 6.95, respectively, with a sensitivity of 0.2 ng/mL. 
All insulin levels were estimated by means of colorimetric 
measurements at 450 nm with an ELISA plate reader 
(Organon Teknika, Roseland, NJ, USA) by interpolation 
from a standard curve. Samples were analyzed in duplicate 
and results were expressed as ng of insulin serum mL-1.
In vitro assays
Formation of advanced glycation end-products in the 
bovine serum albumin/glucose and fructose systems
 Advanced glycation end-products (AGE) were 
formed in the in vitro system using a previously described 
method (Kiho et al., 2004). In brief, BSA (10 mg/mL) 
in phosphate buffered-saline (PBS, pH 7.4) containing 
0.02% sodium azide was incubated with glucose (500 
mM) or fructose (100 mM) at 37 °C for 14 and 28 days in 
the absence (control) and presence of the CE, BF or ARF 
of M. x paradisiaca (2.5 and 5.0 μg/mL). The protein, 
glucose or fructose, and the prospective inhibitor were 
simultaneously introduced into the incubation mixture. 
Each solution was kept in the dark in a capped vial, and 
incubation was allowed to proceed in triplicate vials. To 
the time-course experiments on AGE formation it was 
measured the characteristic fluorescence (excitation 
wavelength of 370 nm and emission wavelength of 440 
nm) with Infiniti M200 (TECAN).
Disaccharidase extraction and assays
 A segment of the small intestine was removed, 
washed in 0.9% NaCl solution, dried on filter paper, 
weighed, trimmed and homogenized (300 rpm) with 0.9% 
NaCl (400 mg of duodenum per mL) for 1 min at 4 ºC. The 
resulting homogenate was centrifuged at 8000 x g for 8 min 
and supernatant was collected. The supernatant was used 
for the measurement of in vitro maltase, sucrase and lactase 
activities and for total protein determination. Maltase (EC 
3.2.1.20), lactase (EC 3.2.1.23) and sucrase (EC 3.2.1.48) 
activities were determined using a glucose diagnosis kit 
based on the glucose oxidase reagent. For determination 
of disaccharidase activity 50 μL of supernatant were pre-
incubated at 37 °C for 5 min, in the absence (control) or 
in the presence of the CE, BF or ARF of M. x paradisiaca 
(treated groups). The concentrations used were 500, 1000 
and 1500 μg/mL. The duodenum supernatant were then 
incubated at 37 °C for 5 min with 25 μL of the substrate 
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corresponding to 0.056 μM of maltose, sucrose or lactose 
(Pereira et al., 2011). One enzyme unit (U) was defined 
as the amount of enzyme that catalyzed the release of 1 
μM of glucose per min under the assay conditions. The 
specific activity was defined as enzyme activity (U) per 
mg of protein. Protein concentration was determined by 
the method described by Lowry et al. (1951) method using 
bovine serum albumin (BSA) as the standard. The assays 
were performed in duplicate and conducted along with 
appropriate controls.
Data and statistical analysis
 Data were expressed as mean±SEM. One-way 
analysis of variance (ANOVA) followed by the Bonferroni 
post-hoc test or unpaired Student’s t-test to identify 
significant differences between groups using the GraphPad 
Prism Software (3.0 version). Differences were considered 
to be significant at p≤0.05.
Results
Phytochemical characterization
 The chemical composition of CE and BF and 
ARF fractions of Musa x paradisiaca were determined 
by TLC and by RP-HPLC. The TLC analyses showed a 
predominance of flavonoids and the major spot detected 
in all analyses showed Rf and color similar to rutin (data 
not shown). Figure 1 shows the HPLC profiles for CE, BF 
and ARF of M. x paradisiaca. These analyzes identified 
the presence of rutin (rt=30.5 min) on crude extracts 
and fractions of M. x paradisiaca leaves as the major 
compound.
Figure 1. HPLC chromatograms of crude extract, aqueous 
residual fraction and n-butanol fraction of leaves of M. x 
paradisiaca with photo-diode array (PDA) detection at 340 nm. 
1. rutin (rt 30.6 min).
Effect of crude extract and n-BuOH and aqueous residual 
fractions of M. x paradisiaca on the oral glucose tolerance 
curve
 As expected, after starting the glucose tolerance 
test the serum glucose concentration was significantly 
increased when compared with zero time. Tolbutamide 
(100 mg/kg) an oral hypoglycemic agent of sulfonylurea 
class was used as a positive control and produced a 
typical serum glucose lowering at 15, 30 and 60 min 
compared to the hyperglycemic group (Table 1). The 
CE at all doses tested (50, 100 and 200 mg/kg) was 
effective in reducing the glycemia at different times 
after oral treatment when compared with the respective 
hyperglycemic control group (Table 1). The CE (200 mg/
kg) produced the best antihyperglycemic profile from 15 
to 60 min and the maximum reduction observed was 19% 
at 30 min, compared to tolbutamide. Table 1 also shows 
the effect of the BF at 50 and 100 mg/kg on oral glucose 
tolerance curve (OGTC). Although both doses showed an 
antihyperglycemic effect, the 50 mg/kg dose was more 
effective in terms of serum glucose lowering than 100 mg/
kg, since it reduced significantly the glycemia at 15, 30 
and 60 min. In addition, oral administration of ARF of 
also reduced the serum glucose levels in hyperglycemic 
rats at the two doses tested (50 and 100 mg/kg). The 
antihyperglycemic effect observed was around 22% and 
25% at 30 and 60 min, respectively, after treatment with 
100 mg/kg. At 180 min, glycemic levels were similar to 
the respective data for the hyperglycemic control groups.
 On the other hand, acute treatments with CE, BF 
and ARF tested were ineffective to change serum glucose 
levels in alloxan-induced diabetic rats (data not shown).
Effect of crude extract and n-BuOH and aqueous residual 
fractions on the glycogen content in soleus muscle and 
liver
 The glycogen content in the soleus muscle and 
liver of hyperglycemic normal rats after acute treatment 
with CE (200 mg/kg), BF (50 mg/kg) and ARF (100 mg/
kg). Figure 2A shows that only BF were able to significantly 
increase the glycogen content in soleus muscle (183%) 
when compared with hyperglycemic control rats at 3 h 
after treatment.
 Additionally, the CE, BF and ARF showed a 
stimulatory effect on hepatic glycogen storage (Figure 
2B). When compared with hyperglycemic rats the CE and 
ARF significantly increased glycogen content in the liver 
around 123 and 136%, respectively. In this experimental 
condition, the maximum effect observed was around 142% 
for the BF. 
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Effect of crude extract and n-BuOH and aqueous residual 
fractions on insulin secretion
 The insulin secretion after in vivo treatment 
with the extract and fractions of M. x paradisiaca was 
measured. Serum insulin levels were determined in fasted 
rats after an oral glucose loading (4 g/kg), as shown in 
Table 2. BF (50 mg/kg) stimulated significantly the insulin 
secretion at 15 min by around 154% when compared to the 
hyperglycemic control group (Table 2). So, the increase 
in glycogen content in the soleus muscle may be due to 
insulin release from β-cells stimulated by BF treatment. 
In addition, the high serum insulin secretion is according 
with the antihyperglycemic effect of the BF at a dose of 50 
mg/kg seen on the glucose tolerance curve (Table 1).
Effect of crude extract and n-BuOH and aqueous residual 
fractions on in vitro albumin glycation
 In the method adopted in this study, BSA was 
chosen as the model protein and glucose or fructose was 
used as the glycated agent. The BSA-reducing sugar 
system is an in vitro model widely used in non-enzymatic 
glycation studies. Proteins can be modified when exposed 
to reducing sugars through the spontaneous glycation 
process. The sugar-mediated fluorescence intensity, which 
is a characteristic of AGE, increases during incubation 
at 37 oC for a long period. In Figure 3A, B, C and D the 
fluorescence intensity of the products (AGE) formed in the 
BSA-glycation model can be observed. After incubation 
for both periods analyzed (14 and 28 days) it was clear that 
the formation of AGE was significantly increased in the 
BSA/glucose (Figure 3A and B) and BSA/fructose (Figure 
3C and D) systems when compared to the basal control 
group.
 Figure 3A shows the in vitro ability of CE and BF 
to suppress the AGE formation in the BSA/glucose system 
after fourteen days of incubation. All concentrations of 
CE, BF and ARF inhibited significantly the formation of 
AGE in the BSA/fructose system after fourteen days of 
incubation (Figure 3C). Also, as shown in Figure 3B and 
D, the CE, BF and ARF exerted stronger inhibitory effect 
on the BSA/glucose and BSA/fructose system after the 28-
day incubation period at both doses tested. 
Effect of crude extract and n-BuOH and aqueous residual 
fractions on the disaccharidases
 
 We observed that CE, BF and ARF were able to 
reduce slightly maltase specific activity at the maximal 
dose tested (1500 μg/mL) after 5 min of in vitro incubation 
when compared with the basal group (Figure 4). The 
Table 1. Acute effect of crude extract (CE), n-butanol fraction (BF) and aqueous residual fraction (ARF) of M. x paradisiaca on 
serum glucose levels (mg/dL) in oral glucose tolerance curve.
Time 
(min)
Group I 
Hyper 
Glucose 
(4 g/kg)
Group II 
Hyper+ 
tolbutamide 
(100 mg/kg)
Group III 
Hyper+ CE
Group IV 
Hyper + BF
Group V 
Hyper + ARF
50 mg/kg 100 mg/kg 200 mg/kg 50 mg/kg 100 mg/kg 50mg/kg 100 mg/kg
0 112±4 111±3 120±3 110±2 110±3 121±4 123±3 103±2 110±5
15 162±8 134±9** 137±8* 145±8 138±3* 128±6** 157±5 148±6 147±4
30 185±6 140±9*** 151±5** 147±7** 150±5*** 152±4** 155±4** 149±4** 144±4***
60 164±4 128±7*** 171±8 139±8* 136±1* 141±6* 143±5 141±5* 123±5***
180 135±4 123±2 143±5 137±3 144±5 142±3 130±3 134±5 129±2
Values are expressed as mean±SEM; n=6 in duplicate for each treatment. Statistically significant difference compared to the corresponding 
hyperglycemic group. *p≤0.05; **p≤0.01; ***p≤0.001.
Table 2. Acute effect of crude extract (CE), n-butanol fraction (BF), and aqueous residual fraction (ARF) of M. x paradisiaca on 
serum insulin levels (ng/mL).
Serum insulin levels in hyperglycemic rats (ng/ml)
Time (min) Control glucose (4 g/kg)
M. x paradisiaca
CE 200 mg/kg BF 50 mg/kg ARF 100 mg/kg
0 0.57±0.03 - - -
15 0.77±0.06# 0.90±0.20 1.29± 0.08** 0.88±0.15
30 0.90±0.10 0.90±0.10 0.92±0.10 0.66±0.01
60 0.54±0.04 0.71±0.08 0.72±0.15 0.73±0.10
Values are expressed as mean±SEM; n=4 in duplicate for each treatment. Statistically significant at #p≤0.01 in relation to euglycemic group. Statistically 
significant difference compared to the corresponding hyperglycemic group. *p≤0.05; **p≤0.01; ***p≤0.001.
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maximum effect was observed for BF which inhibited 20% 
of maltase activity, while this inhibitory effect was around 
13% and 14% for the CE and ARF, respectively. On the 
other hand, none of the treatments affected the sucrase 
and lactase activity at any concentration tested (data not 
shown).
Figure 2. Effect of crude extract (CE), n-butanol fraction (BF) 
and aqueous residual fraction (ARF) and of leaves of M. x 
paradisiaca on the glycogen content in normal hyperglycemic 
rats. A. soleus muscle and B. liver 3 h after treatment by oral 
gavage. Control group is the hyperglycemic rats without 
treatment. Values are expressed as mean±SEM; n=6 in duplicate 
for each group. Significantly different to the corresponding 
hyperglycemic group; *p≤0.05; **p≤0.01; ***p≤0.001.
Discussion
 In the present study, we demonstrated the 
beneficial effects of M. x paradisiaca leaves on the 
regulation of glucose homeostasis. Antihyperglycemic 
potency of extract and fractions, n-butanol and aqueous 
residual, was demonstrated here by glucose levels 
decreased, glycogen and plasma insulin levels increased 
after M. x paradisiaca administration in hyperglycemic 
rats. We have also observed that M. x paradisiaca inhibited 
maltase activity and the formation of AGE in vitro. The 
present study highlights the ability of Musa x paradisiaca 
leaves to improve carbohydrate metabolism.
 The phytochemical analysis demonstrated the 
presence of flavonoids in crude extract and fractions of 
M. x paradisiaca leaves and rutin is the major compound. 
The presence of a variety of phenolic compounds has 
been reported in many parts of Musa species and these 
phytochemicals have been associated with the observed 
biological activity of these plants. However, to the best of 
our knowledge, this is the first report of the presence of 
rutin in the leaves of M. x paradisiaca. 
 Rutin (quercetin-3-O-rutinoside), a flavonol 
glycoside, is a pharmacologically active phytochemical 
which exhibits multiple biological activities. We 
have previously reported that rutin modulate glucose 
homeostasis. Rutin decrease glycemia, increase insulin 
secretion and inhibit α-glucosidase (Pereira et al., 2011, 
Kappel et al, 2013a,b). Also, we have demonstrated the 
mechanism of action of rutin in relation to glucose uptake 
in skeletal muscle and insulin secretion in pancreatic islets 
(Pereira et al., 2011, Kappel et al, 2013a,b). 
 Several medicinal plants show potential 
hypoglycemic and/or antihyperglycemic activity, 
including Musa. Intra-gastric administration of a fresh 
flower decoction (4 mL/kg) to hyperglycemic rabbits 
significantly decreased the hyperglycemic peak and/or 
the area under the glucose tolerance curve (Alarcon-
Aguilara et al., 1998). Furthermore, it has been reported 
in the literature that the extracts of other parts of 
different Musa species showed a hypoglycemic effect 
in diabetic animal models (Ojewole & Adewunmi, 
2003; Mallick et al., 2006; Adewoye et al., 2009). Pari 
& Maheswari (1999) observed that in a chronic daily 
treatment the oral administration of various doses of 
the chloroform extract of M. sapientum flowers reduced 
blood glucose levels in alloxanized rats. Similarly, it 
has been shown that pectin isolated from the juice of 
the inflorescence of M. sapientum showed significant 
hypoglycemic effect in alloxan-induced diabetic rats 
(Gomathy et al., 1990). More recently, Adewoye et 
al. (2009) demonstrated an antidiabetic activity for 
aqueous and methanolic extracts of M. sapientum roots 
in alloxan-induced diabetic rats.
 Also, a hypoglycemic effect of a methanolic 
extract of M. x paradisiaca fruit in streptozotocin-induced 
diabetic mice was demonstrated (Ojewole & Adewunmi, 
2003). Additionally, a composite extract of seeds of 
Eugenia jambolana and roots of M. x paradisiaca showed 
antihyperglycemic and anti-hyperlipidemic effect in 
streptozotocin-induced diabetic albino rats (Mallick et al., 
2006). However all these works did not investigated the 
pharmacological activity as well as did not identify the 
bioactive compound present in the extracts of the leaves 
of M. x paradisiaca. In the present study, we demonstrated 
the significant antihyperglycemic effect of extract and 
fractions of M. x paradisiaca leaves.
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Figure 4. In vitro effect of crude extract (CE), n-butanol fraction 
(BF) and aqueous residual fraction (ARF) of leaves of M. x 
paradisiaca on specific activity of maltase, in the duodenal portion 
of rat intestine. Control group without treatment represents 100 
% of specific activity of maltase. Incubation: 5 min. Values are 
expressed as mean±SEM; n=6 for each group. Significant at 
*p≤0.05 compared to control group.
 In mammals, carbohydrate is stored mainly in 
the form of glycogen, with skeletal muscle and liver being 
the major storage sites. Glycogen metabolism is regulated 
by insulin/glucagon through activation and/or inhibition 
of several enzymes and proteins (Ferrer et al., 2003). The 
present results demonstrated that BF of M. x paradisiaca 
leaves significantly increased the glycogen content in 
soleus muscle and liver. The high amount of rutin into BF 
can be involved on increased muscle glycogen content after 
acute treatment, since Fernandes et al. (2010) reported that 
treatment with rutin was associated with a marked elevation 
on glycogen in rats in streptozotocin-induced diabetes. It 
was observed that the hepatic and cardiac tissue glycogen 
content increased significantly in treated diabetic rats when 
compared to untreated diabetic rats. Furthermore, we have 
demonstrated that rutin stimulated glucose uptake in the 
soleus muscle (Kappel et al, 2013a) and this effect could 
be related with the increase on muscle glycogen content 
with BF treatment. 
 Additionally, CE and ARF also showed a 
stimulatory effect on hepatic glycogen storage. In line with 
these results, it has been reported that rats fed with dietary 
fiber from Musa, showed significant lower levels of fasting 
blood glucose and higher concentrations of liver glycogen. 
Figure 3. Inhibitory effect of crude extract (CE), n-butanol fraction (BF) and aqueous residual fraction (ARF) of leaves of M. x 
paradisiaca on the fluorescent AGE formation in a BSA/glucose or BSA/fructose system. A and B. 14 and 28-days BSA/glucose; C 
and D. 14 and 28-days BSA/fructose. Values are expressed as mean±SEM; n=6 in duplicate for each group. Significantly different to 
the corresponding control group (BSA/glucose or BSA/fructose); ***p≤ 0.001.
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Also, the activities of some enzymes of glycolysis were 
inhibited (Usha et al., 1989).
 The stimulation of β-cells, subsequent release 
of insulin and activation of the insulin receptors is a 
possible mechanism of natural products with potential 
antidiabetic activity. In the present study, it was 
demonstrated that BF potentiated significantly the 
glucose-induced insulin secretion. In this line, Folador 
et al. (2010) showed that the crude extract, n-butanol 
fraction and two isolated C-glycosylflavones, isovitexin 
and swertisin, of Wilbrandia ebracteata produced 
antihyperglycemic action, related to in vivo insulin 
secretion.
 Additionally, flavonoids are reportedly insulin 
secretagogues. Genistein and daidzein have been found to 
increase insulin secretion stimulated by glucose in vivo and 
in vitro (Liu et al., 2006). Also, rutin has been reported to 
enhance insulin release and decrease blood glucose levels 
(Kamalakkannan & Prince 2006). Recently, we also have 
demonstrated that rutin reduce glycemia and potentiate in 
vivo insulin secretion (Kappel et al, 2013b). Thus, rutin, 
a potential insulin-secretagogue agent, which is found in 
quite high amounts in the BF, is thought to be related to the 
antihyperglycemic activity observed in the present study 
for M. x paradisiaca. 
 Chronic hyperglycemia and increased oxidative 
stress during diabetes results in the irreversible formation of 
AGE, which are related with development and progression 
of diabetic complications, like nephropathy, neuropathy, 
retinopathy, and cardiovascular diseases (Goh & Cooper, 
2008). Our results indicated that extract and fractions of 
M. x paradisiaca leaves exerted stronger inhibitory effect 
on AGE formation. In line with these results, Bhaskar et 
al. (2011) also showed that the flower and pseudostem of 
Musa sp. var. elakki bale inhibited the formation of AGE 
in rats with streptozotocin-induced diabetes, showing the 
anti-AGE properties of Musa sp.
 Also, the presence of flavonoids such as rutin 
may be related to inhibit the formation of AGE (Pashikanti 
et al., 2010), as we have demonstrated for the extract and 
fractions of M. x paradisiaca, particularly for the BF 
which presented the highest content of rutin and showed 
the best anti-AGE effect. In agreement with these results, 
anti-AGE effect was also previously reported for other 
flavonoids (Wu & Yen 2005).
 The α-glucosidase inhibitors delay the absorption 
of ingested carbohydrates, reducing the postprandial 
glycemia and insulin peaks (De Melo & Carvalho 
2006). In the present study, we demonstrated that extract 
and fractions of M. x paradisiaca leaves reduced the 
maltase activity. A number of plants are known to exert 
antihyperglycemic activity through the inhibition of 
carbohydrate-hydrolyzing enzymes in the small intestine. 
The polyphenols in plants play an important role in the 
mechanism for regulating these disaccharidases. Andrade-
Cetto et al. (2008) reported that flavonoid-enriched 
extracts from some Mexican plants efficiently inhibited 
α-glucosidase activity and significantly reduced serum-
glucose levels in diabetic rats. More recently, the effect 
of different flavonoids, including rutin, on rat intestinal 
disaccharidase inhibition with a consequent reduction 
in the intestinal glucose absorption has been described 
(Pereira et al., 2011).
 In conclusion, we showed that the crude 
extract, n-butanol and aqueous residual fractions of M. 
x paradisiaca leaves exhibit potential antihyperglycemic 
action. The reduction on serum glucose levels, stimulation 
of insulin secretion, stimulation of glycogen storage, and 
inhibition of enzyme activity related to glucose absorption 
and AGE formation corroborates the beneficial effects on 
the regulation of glucose homeostasis observed for M. x 
paradisiaca leaves. In addition, M. x paradisiaca leaves 
that in general there is no commercial interest can provide 
an excellent source of rutin, which is a candidate for the 
development of anti-diabetic drugs in the near future.
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